185 related articles for article (PubMed ID: 24896364)
41. Treating patients with schizophrenia deficit with erythropoietin?
Fond G; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Capdevielle D
Psychiatry Clin Neurosci; 2012 Aug; 66(5):375-82. PubMed ID: 22725970
[TBL] [Abstract][Full Text] [Related]
42. Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.
Shein NA; Grigoriadis N; Alexandrovich AG; Simeonidou C; Spandou E; Tsenter J; Yatsiv I; Horowitz M; Shohami E
J Neurotrauma; 2008 Feb; 25(2):112-23. PubMed ID: 18260794
[TBL] [Abstract][Full Text] [Related]
43. Intranasal erythropoietin therapy in nervous system disorders.
Genc S; Zadeoglulari Z; Oner MG; Genc K; Digicaylioglu M
Expert Opin Drug Deliv; 2011 Jan; 8(1):19-32. PubMed ID: 21143002
[TBL] [Abstract][Full Text] [Related]
44. Effects of erythropoietin on neonatal hypoxia-ischemia brain injury in rat model.
Ren Q; Jiang ZH; Zhang XF; Yang QZ
Physiol Behav; 2017 Feb; 169():74-81. PubMed ID: 27887996
[TBL] [Abstract][Full Text] [Related]
45. Seizure-induced neurogenesis: are more new neurons good for an adult brain?
Parent JM; Lowenstein DH
Prog Brain Res; 2002; 135():121-31. PubMed ID: 12143334
[TBL] [Abstract][Full Text] [Related]
46. The combined therapy of intrahippocampal transplantation of adult neural stem cells and intraventricular erythropoietin-infusion ameliorates spontaneous recurrent seizures by suppression of abnormal mossy fiber sprouting.
Jing M; Shingo T; Yasuhara T; Kondo A; Morimoto T; Wang F; Baba T; Yuan WJ; Tajiri N; Uozumi T; Murakami M; Tanabe M; Miyoshi Y; Zhao S; Date I
Brain Res; 2009 Oct; 1295():203-17. PubMed ID: 19646969
[TBL] [Abstract][Full Text] [Related]
47. Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases.
Ureña-Guerrero ME; Castañeda-Cabral JL; Rivera-Cervantes MC; Macias-Velez RJ; Jarero-Basulto JJ; Gudiño-Cabrera G; Beas-Zárate C
Curr Pharm Des; 2020; 26(12):1263-1276. PubMed ID: 31942853
[TBL] [Abstract][Full Text] [Related]
48. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke.
Gonzalez FF; McQuillen P; Mu D; Chang Y; Wendland M; Vexler Z; Ferriero DM
Dev Neurosci; 2007; 29(4-5):321-30. PubMed ID: 17762200
[TBL] [Abstract][Full Text] [Related]
49. Neuroprotective agents and modulation of temporal lobe epilepsy.
Fernandes MJ; Carneiro JE; Amorim RP; Araujo MG; Nehlig A
Front Biosci (Elite Ed); 2015 Jan; 7(1):79-93. PubMed ID: 25553365
[TBL] [Abstract][Full Text] [Related]
50. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery.
Tsai PT; Ohab JJ; Kertesz N; Groszer M; Matter C; Gao J; Liu X; Wu H; Carmichael ST
J Neurosci; 2006 Jan; 26(4):1269-74. PubMed ID: 16436614
[TBL] [Abstract][Full Text] [Related]
51. Erythropoietin: when liability becomes asset in neurovascular repair.
Grant MB; Boulton ME; Ljubimov AV
J Clin Invest; 2008 Feb; 118(2):467-70. PubMed ID: 18219388
[TBL] [Abstract][Full Text] [Related]
52. Neuroprotection with erythropoietin in preterm and/or low birth weight infants.
Zhang J; Wang Q; Xiang H; Xin Y; Chang M; Lu H
J Clin Neurosci; 2014 Aug; 21(8):1283-7. PubMed ID: 24650681
[TBL] [Abstract][Full Text] [Related]
53. Preconditioning-mediated neuroprotection through erythropoietin?
Dawson TM
Lancet; 2002 Jan; 359(9301):96-7. PubMed ID: 11809248
[No Abstract] [Full Text] [Related]
54. The effects of erythropoietin on neurogenesis after ischemic stroke.
Zhang SJ; Luo YM; Wang RL
J Integr Neurosci; 2020 Sep; 19(3):561-570. PubMed ID: 33070534
[TBL] [Abstract][Full Text] [Related]
55. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research.
Sargin D; Friedrichs H; El-Kordi A; Ehrenreich H
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):573-94. PubMed ID: 21619868
[TBL] [Abstract][Full Text] [Related]
56. The PI3K/Akt and ERK1/2 signaling pathways mediate the erythropoietin-modulated calcium influx in kainic acid-induced epilepsy.
Zheng H; Wang X; Tang Z; Zheng W; Li Z
Neuroreport; 2013 Apr; 24(6):335-41. PubMed ID: 23518641
[TBL] [Abstract][Full Text] [Related]
57. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential.
Dame C; Juul SE; Christensen RD
Biol Neonate; 2001; 79(3-4):228-35. PubMed ID: 11275657
[TBL] [Abstract][Full Text] [Related]
58. Erythropoietin: novel approaches to neuroprotection in human brain disease.
Ehrenreich H; Aust C; Krampe H; Jahn H; Jacob S; Herrmann M; Sirén AL
Metab Brain Dis; 2004 Dec; 19(3-4):195-206. PubMed ID: 15554415
[TBL] [Abstract][Full Text] [Related]
59. Converging early responses to brain injury pave the road to epileptogenesis.
Neuberger EJ; Gupta A; Subramanian D; Korgaonkar AA; Santhakumar V
J Neurosci Res; 2019 Nov; 97(11):1335-1344. PubMed ID: 29193309
[TBL] [Abstract][Full Text] [Related]
60. Erythropoietin and derivatives: Potential beneficial effects on the brain.
Vittori DC; Chamorro ME; Hernández YV; Maltaneri RE; Nesse AB
J Neurochem; 2021 Sep; 158(5):1032-1057. PubMed ID: 34278579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
